OGN

Organon & Co. (OGN)

About Organon & Co. (OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Details

Daily high

$14.92

Daily low

$14.41

Price at open

$14.50

52 Week High

$23.10

52 Week Low

$13.65

Market cap

3.8B

Dividend yield

7.68%

Volume

31.6M

Avg. volume

4.6M

P/E ratio

2.89

Organon & Co. News